for the IXORA-PEDS Investigators | Clinic for Dermatology, Venereology and Allergology, University Hospital Frankfurt am Main, Frankfurt, Germany | Department of Dermatology, ...
Is this your profile? Claim your profile Copy URL Embed Link to your profile
Andreas Pinter:Expert Impact
Concepts for whichAndreas Pinterhas direct influence:Hidradenitis suppurativa,Lichen planus,Patients hidradenitis suppurativa,Clindamycin rifampicin,Treatment hidradenitis,Patients hidradenitis,Suppurativa humans.
Andreas Pinter:KOL impact
Concepts related to the work of other authors for whichfor which Andreas Pinter has influence:Hidradenitis suppurativa,Lichen planus,Skin microbiome,Rna therapeutics,Patients biologic therapy,Vivo culture,Lipid nanoparticle.
KOL Resume for Andreas Pinter
for the IXORA-PEDS Investigators
Department of Dermatology, Venereology and Allergology, University Hospital Frankfurt am Main, Germany.
Klinik für Dermatologie, Allergologie und Venerologie, Klinikum der J.W. Goethe‐Universität
Prominent publications by Andreas Pinter
The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa: Results of a prospective European cohort study
[ PUBLICATION ]
BACKGROUND: Tetracyclines and clindamycin plus rifampicin combination therapy are both considered first-line therapy in current hidradenitis suppurativa guidelines. However, evidence for their efficacy is drawn from small studies, often without validated outcomes.
OBJECTIVE: To assess the 12-week efficacy of oral tetracyclines and a combination of clindamycin and rifampicin.
METHODS: A prospective, international cohort study performed between October 2018 and August 2019.
RESULTS: In ...
|Known for Hidradenitis Suppurativa | Clindamycin Rifampicin | Patient Characteristics | 12 Weeks|